Prot#IDN-6556-14: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects with Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension

Project: Research project

Project Details

StatusFinished
Effective start/end date10/5/1710/5/20

Funding

  • PPD Investigator Services, LLC (Prot#IDN-6556-14)
  • Conatus Pharmaceuticals Inc. (Prot#IDN-6556-14)